Acute respiratory distress syndrome after emapalumab treatment in a child with severe Still's disease and lung involvement: a case report

Federica Anselmi^{1

2}, Arnaud Terzic³, Véronique Despert⁴, Linda Rossi-Semerano¹, Isabelle Koné-Paut^{1

2}, Perrine Dusser^{1

2}

Affiliations

¹ Paediatric Rheumatology Department and CEREMAIA (Reference Center for Auto-Inflammatory Diseases and Amyloidosis), Bicêtre University Hospital (APHP-Assistance Publique-Hopitaux de Paris), Le Kremlin Bicêtre, Paris, France.
² Faculty of Medecine, University of Paris-Saclay, Paris, France.
³ Intensive Care Unit, Bicêtre University Hospital, Le Kremlin Bicêtre, Paris, France.
⁴ Paediatric Rheumatology Department, Tours University Hospital, Tours, France.

Federica Anselmi et al. Rheumatology (Oxford). 2025.

. 2025 Apr 1;64(4):2317-2319.

doi: 10.1093/rheumatology/keae642.

Federica Anselmi^{1

2}, Arnaud Terzic³, Véronique Despert⁴, Linda Rossi-Semerano¹, Isabelle Koné-Paut^{1

2}, Perrine Dusser^{1

2}

¹ Paediatric Rheumatology Department and CEREMAIA (Reference Center for Auto-Inflammatory Diseases and Amyloidosis), Bicêtre University Hospital (APHP-Assistance Publique-Hopitaux de Paris), Le Kremlin Bicêtre, Paris, France.
² Faculty of Medecine, University of Paris-Saclay, Paris, France.
³ Intensive Care Unit, Bicêtre University Hospital, Le Kremlin Bicêtre, Paris, France.
⁴ Paediatric Rheumatology Department, Tours University Hospital, Tours, France.

No abstract available

Comment in

Comment on: Acute respiratory distress syndrome after emapalumab treatment in a child with severe Still's disease and lung involvement: a case report.
Saper VE, Verstegen RHJ. Saper VE, et al. Rheumatology (Oxford). 2025 Aug 1;64(8):4860-4861. doi: 10.1093/rheumatology/keaf117. Rheumatology (Oxford). 2025. PMID: 40036577 No abstract available.